<?xml version="1.0" encoding="UTF-8"?>
<p id="Par23">α-synuclein (SNCA) is a presynaptic protein and a major component of Lewy pathology. Studies of familial forms of Parkinson’s disease have identified 
 <italic>SNCA</italic> missense mutations and genomic multiplications
 <sup>
  <xref ref-type="bibr" rid="CR111">111</xref>
 </sup>. Mice models overexpressing mutant or wild type human α-synuclein mostly exhibit reduced DAT expression and dopamine reuptake
 <sup>
  <xref ref-type="bibr" rid="CR112">112</xref>–
  <xref ref-type="bibr" rid="CR116">116</xref>
 </sup> with some exceptions
 <sup>
  <xref ref-type="bibr" rid="CR117">117</xref>
 </sup>. α-synuclein may form a stable complex with DAT in heterologous systems, rodent and human striatal tissues
 <sup>
  <xref ref-type="bibr" rid="CR25">25</xref>,
  <xref ref-type="bibr" rid="CR118">118</xref>,
  <xref ref-type="bibr" rid="CR119">119</xref>
 </sup>. Studies in dopaminergic neuronal cultures suggest DAT/α-synuclein association negatively regulates DAT reuptake activity
 <sup>
  <xref ref-type="bibr" rid="CR120">120</xref>–
  <xref ref-type="bibr" rid="CR122">122</xref>
 </sup> possibly by redistributing surface DAT to cholesterol-rich microdomains and altering ionic coupling of DAT mediated current
 <sup>
  <xref ref-type="bibr" rid="CR120">120</xref>,
  <xref ref-type="bibr" rid="CR121">121</xref>
 </sup>. DAT surface expression, measured by biotinylation, is also reduced with co-expression of wild type α-synuclein
 <sup>
  <xref ref-type="bibr" rid="CR123">123</xref>,
  <xref ref-type="bibr" rid="CR124">124</xref>
 </sup>. When compared to wild type α-synuclein, the PD-linked missense mutation 
 <italic>SNCA</italic> p.A30P enhances DAT α-synuclein interaction and further reduces DAT surface expression and function; in contrast, p.A53T does not form a strong protein-protein complex with DAT, nor modulates DAT function or surface expression. Although 
 <italic>SNCA</italic> p.A30P and p.A53T have disparate effects on DAT-binding and trafficking, they are N’-terminal located on the hydrophobic face of α-synuclein’s amphipathic helix, highlighting the importance of maintaining that protein-lipid interaction.
</p>
